Safety and Efficacy Study of Umbilical Cord-Derived Mesenchymal Stem Cells for Rheumatoid Arthritis
Status:
Unknown status
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Rheumatoid arthritis is a chronic systemic disease, which is characterized by chronic
inflammation in the synovial tissue. Rheumatoid arthritis will eventually result in the
destruction of cartilage, bone and ligaments and joint deformity. The underlying hypothesis
is that umbilical cord-derived mesenchymal stem cell (UC-MSCs) has anti-inflammatory effects
and thus potentially alleviates the progression of rheumatoid arthritis. The study is to
explore the safety and efficacy of UC-MSCs transplantation in treatment of rheumatoid
arthritis.